Ampio Pharmaceuticals Inc (AMPE):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Ampio Pharmaceuticals Inc (AMPE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C8110)・商品コード:DATA904C8110
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:33
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Ampio Pharmaceuticals Inc (Ampio), formerly Chay Enterprises Inc is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level. It provides products for the treatment of osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases. Ampio’s products include low molecular weight fraction of human serum albumin and ultra-low dose of danazol. Its ultra-low dose of danazol is used for the oral treatment of diabetic macular edema. The company conducts research on various future indications for optina. It partners with other biopharmaceutical companies for its research activities. Ampio is headquartered in Englewood, Colorado, the US.

Ampio Pharmaceuticals Inc (AMPE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ampio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Merger 11
Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 11
Licensing Agreements 12
FBM FARMA Industria Farmaceutica Enters Into Licensing Agreement With Ampio Pharma For Zertane 12
Equity Offering 13
Ampio Pharma Prices Public Offering of Shares and Warrants for USD8 Million 13
Ampio Pharma Raises USD6.7 Million Private Placement of Shares 14
Ampio Pharma Raises USD6.6 Million in Private Placement of Shares and Warrants 15
Ampio Pharma Raises USD3.8 Million in Private Placement of Shares and Warrants 17
Ampio Pharma Raises up to USD25 Million in Public Offering of Shares 19
Aytu BioScience Spin-Off from Ampio Pharma 20
Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 21
Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 22
Ampio Pharma Completes First Tranche Of Private Placement Of Shares 23
Ampio Pharma Completes Public Offering Of Shares For US$17 Million 24
Ampio Pharmaceuticals Inc – Key Competitors 25
Ampio Pharmaceuticals Inc – Key Employees 26
Ampio Pharmaceuticals Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Corporate Communications 28
Nov 16, 2017: Ampio Pharmaceuticals Announces Continued Listing Plan Accepted by NYSE American 28
Jun 12, 2017: Ampio Announces Appointment of Interim Chief Financial Officer 29
Other Significant Developments 30
May 14, 2018: Ampio Provides Corporate Update 30
Mar 15, 2018: Ampio Pharmaceuticals Provides Corporate Update Following Conference Call 31
Mar 20, 2017: Ampio Pharmaceuticals Provides Corporate Update 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ampio Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Ampio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 11
FBM FARMA Industria Farmaceutica Enters Into Licensing Agreement With Ampio Pharma For Zertane 12
Ampio Pharma Prices Public Offering of Shares and Warrants for USD8 Million 13
Ampio Pharma Raises USD6.7 Million Private Placement of Shares 14
Ampio Pharma Raises USD6.6 Million in Private Placement of Shares and Warrants 15
Ampio Pharma Raises USD3.8 Million in Private Placement of Shares and Warrants 17
Ampio Pharma Raises up to USD25 Million in Public Offering of Shares 19
Aytu BioScience Spin-Off from Ampio Pharma 20
Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 21
Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 22
Ampio Pharma Completes First Tranche Of Private Placement Of Shares 23
Ampio Pharma Completes Public Offering Of Shares For US$17 Million 24
Ampio Pharmaceuticals Inc, Key Competitors 25
Ampio Pharmaceuticals Inc, Key Employees 26
Ampio Pharmaceuticals Inc, Subsidiaries 27

List of Figures
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ampio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ampio Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[Ampio Pharmaceuticals Inc (AMPE):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C8110)販売に関する免責事項を必ずご確認ください。
★調査レポート[Ampio Pharmaceuticals Inc (AMPE):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆